Cellular Biomedicine Group
Cupertino, US · Delaware corporation
Find your way into Cellular Biomedicine Group
1,764 people in our graph share verified history with the Cellular Biomedicine Group team — schools, employers, funds. One of them is your warm intro.
Yaryna Nychunlockedknows Yihong Yao · together at Harvard University (overlapped)
×7knows the team · via Harvard University
×2knows the team · via Boston University
×2knows the team · via Spotfire
Founders & leadership
W(
Wei (William) CaoinFounderWei Cao is an Executive Officer and Director at Gracell Biotechnologies, a cellular gene therapy company founded in 2017 and headquartered in Suzhou, China.
AC
Andrew ChanExecutive
YY
Yihong YaoinChief Scientific OfficerYihong Yao is an executive officer at Cellular Biomedicine Group with over 14 years of experience in pharmaceutical and biotechnology companies. He has developed expertise in clinical biomarker discovery, companion diagnostic development, and personalized medicine, including work on gene signature-based diagnostics and next-generation sequencing approaches, with 25 patents filed and over 50 peer-reviewed publications to his name.
T(
Tony (Bizuo) LiuExecutive
B(
Bizou (Tony) LiuExecutive
Board
CK
Chun Kwok Alan AuBoard director
TA
Terry A. BelmontBoard director
NP
Nadir PatelBoard director
GJ
Gang JiBoard director
HZ
Hansheng ZouBoard director
W(
Wen (Steve) Tao LiuBoard director
JA
Jeff AuerbachBoard director
Reported raises · per SEC filings
Form D private placements$37.5M disclosed across 2 rounds · 2013–2018
▶$30.6MraisedFeb 2018 · 3 investors · BiotechnologyRule 506(b)
▶$30.6MraisedFeb 2018 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chun Kwok Alan AuDirector
- Terry A. BelmontExecutive Officer, Director
- Nadir PatelDirector
- Gang JiDirector
- Hansheng ZouDirector
- Andrew ChanExecutive Officer
- Yihong YaoExecutive Officer
- Wen (Steve) Tao LiuDirector
- Tony (Bizuo) LiuExecutive Officer
- Offering amount
- $30.6M
- Amount sold
- $30.6M
- Proceeds to insiders
- $30.6M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedApr 2014 · 12 investors · BiotechnologyRule 506(b)
▶$6.9MraisedApr 2014 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff AuerbachDirector
- Wen Tao (Steve) LiuDirector
- Gerardus HooglandDirector
- Terry A. BelmontDirector
- David BolocanDirector
- Bizou (Tony) LiuDirector
- Andrew ChanExecutive Officer
- Jainping DaiDirector
- Nadir PatelDirector
- Wei (William) CaoExecutive Officer, Director
- Keith WongDirector
- Offering amount
- $7M
- Amount sold
- $6.9M
- Minimum investment
- $22K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Cellular Biomedicine Group went on to found or lead other companies.
In the news
Frequently asked questions
- Who founded Cellular Biomedicine Group?
- Cellular Biomedicine Group was founded by Wei (William) Cao.
- How much funding has Cellular Biomedicine Group raised?
- Cellular Biomedicine Group has disclosed $37.5M raised across 2 rounds.
- Where is Cellular Biomedicine Group headquartered?
- Cellular Biomedicine Group is headquartered in Cupertino, US.